Body composition and metabolic manifestations of insulin resistance in adolescents with polycystic ovary syndrome: Ectopic fat deposition and metabolic markers - baseline study
Body composition and metabolic manifestations of PCOS
Sponsor: NA
Enrolling: Female Patients Only
Study Length: 1 Days
Clinic Visits: 1
IRB Number: AAAA7793
U.S. Govt. ID: NCT02506946
Contact: Claire Burghard: 212-305-1518 / acb2217@cumc.columbia.edu
Additional Study Information: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women ofreproductive age, affecting about 7% of this population when using the strictest diagnostic criteria and frequently presents in adolescence and young adulthood. Diagnostic features of PCOS includehyperandrogenism and ovulatory dysfunction. Additionally, both obese and nonobese individuals with PCOS frequently develop features of the metabolic syndrome, including insulin resistance anddyslipidemia. In fact, insulin resistance affects up to 70% of those affected with PCOS and has beenincreasingly implicated to underlie the hormonal and metabolic derangements as well as the clinicalabnormalities of PCOS. Early identification and treatment of the metabolic and body compositionabnormalities associated with PCOS will potentially prevent lifelong morbidity associated with thisdisorder, which is significant in light of the large numbers of young individuals with PCOS and theirincreased risk of development of IR, NAFLD and dyslipidemia. We are recruiting healthy adolescent girls and young women with and without PCOS between the ages of 13 and 25 years to participate in a study to help better define the metabolic and body composition abnormalities associated with PCOS.
This study is closed
Investigator
Aviva Sopher, MD, MS
Do You Qualify?
Are you an adolescent girl/young woman between the ages of 13 and 21? Yes No
Do you take any hormonal mediacations including oral contraception? Yes No
Do you take metformin or other insulin sensitizing medications? Yes No
Do you take any steroidal anti-inflammatory medications? Yes No
Did you start getting your period at least 2 years ago? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Claire Burghard
acb2217@cumc.columbia.edu
212-305-1518